Pharmesis International Ltd. provided earnings guidance for the second quarter and first half of 2019. The Board of Directors of the company announced that after preliminary assessment of the group's unaudited financial results for the second quarter and half year ended 30 June 2019, the board advised that the group is expected to report a net loss for the second quarter of 2019 and first half of 2019. The expected net loss was mainly attributed to lower sales during the second quarter of 2019 and first half the year 2019.